XML 41 R12.htm IDEA: XBRL DOCUMENT

WARRANTS

9 Months Ended

Sep. 30, 2022

NOTE 6 – WARRANTS

For the nine-month period ended September 30, 2022, no warrants were granted, and 3,027 expired. For the nine-month period ended September 30, 2022, warrants to purchase 14,584 shares of common stock were exercised, resulting in proceeds of $875. The Company delivered 14,584 shares of common stock.

The Company uses the Black-Scholes pricing model to estimate the fair value of stock-based awards on the date of the grant.

There was no compensation cost related to the warrants for the nine months ended September 30, 2022 and 2021, respectively.

The Company’s outstanding and exercisable warrants as of September 30, 2022, are presented below:

	Number Outstanding			Weighted Average Exercise Price		Contractual Life In Years
Warrants outstanding as of December 31, 2021		44,535		$	0.32		0.95	$	208,078
Warrants granted		-			-		-		-
Warrants forfeited, expired, cancelled		(3,027	)		3.90		-		-
Warrants exercised		(14,584	)		0.06		-		-
Warrants outstanding as of September 30, 2022		26,924		$	0.06		0.75	$	28,809
Warrants exercisable as of September 30, 2022		26,924		$	0.06		0.75	$	28,809